Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein Kinases and Parkinson’s Disease

20 Sept 2016

Abstract excerpt

Currently, the lack of new drug candidates for the treatment of major neurological disorders such as Parkinson's disease has intensified the search for drugs that can be repurposed or repositioned for such treatment. Typically, the search focuses on drugs that have been approved and are used clinically for other indications. Kinase inhibitors represent a family of popular molecules for the treatment and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27657053
DOI: 10.3390/ijms17091585

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein Kinases and Parkinson’s DiseasePMID 27657053Read ↗

Protein Kinases Linked to the Pathogenesis of Parkinson's DiseaseSemantic proximity Read ↗

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.Semantic proximity Read ↗

Kinase signaling pathways as potential targets in the treatment of Parkinson's disease.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease: Updated from Pathogenesis to Potential Therapeutic TargetSemantic proximity Read ↗

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative DiseaseSemantic proximity Read ↗

Protein Kinases and Neurodegenerative DiseasesSemantic proximity Read ↗

Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.Semantic proximity Read ↗

Unraveling the AKT/ERK cascade and its role in Parkinson diseaseSemantic proximity Read ↗

Characterizing the role of the dark kinome in neurodegenerative disease – A mini reviewSemantic proximity Read ↗

Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.Semantic proximity Read ↗

Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's diseaseSemantic proximity Read ↗

MAPKs: new targets for neurodegenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.